Abiopharma

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

Cove Kaz Capital Group and Qazgeology Provide Exploration Update on Akbulak Rare Earth Project in Kazakhstan

RBB Bancorp Announces Authorized Common Stock Repurchase Plan and Partial Redemption of Subordinated Debt

LandBridge Forms Special Committee to Evaluate Potential Corporate Conversion

Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare

CELSIUS HOLDINGS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Celsius Holdings, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CELH

Patriot Bank Expands High Net Worth Banking Platform in Greenwich, CT

Total Voting Rights and Transaction in Own Shares

Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026

Capstone Energy+ to Host Fourth Quarter and Full Fiscal Year 2026 Earnings Conference Call on June 25, 2026